At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Dydrogesteronedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Duphaston® Tablets 5 mg - A Survey on Efficacy and Safety in Patients With Endometriosis
In Brief
An observational study evaluating Dydrogesterone for Endometriosis. Completed, enrolled 60 participants across 15 sites.
Detailed Summary
This survey is intended to collect efficacy and safety data of Duphaston® Tablets in patients with endometriosis under actual condition of its use and to obtain data for effectively and safely utilizing this drug.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEndometriosis
CountriesJapan
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartAug 2016
First PostedOct 2016
Primary CompletionSep 2017
Study CompletionOct 2017
TodayJul 2026
First PostedOct 3, 2016
Enrollment StartAug 23, 2016
Primary CompletionSep 21, 2017
Study CompletionOct 13, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.7 years ago
Interventions
Dydrogesteronedrug